Acquired food aversion and quality of life in women with beast cancer
Keywords:
Breast neoplasms, Feeding behavior, Quality of life, Drug therapyAbstract
Objective
The objective of this paper was to assess the eating behavior of women with breast cancer subjected to chemotherapy and its relation with the quality of life of these patients.
Methods
A total of 25 women receiving care at the Hospital AC Camargo (SP, Brazil) from October 2005 to April 2006 were selected based on a clinical assay of the before and after type. The patients included in the study were diagnosed with breast cancer, stages I and II and had indication of adjuvant chemotherapy. At the times T0 (before) and T1 (after chemotherapy), the eating behavior (food intake and aversion) was assessed by three 24-hour recalls and the Food Action questionnaire, respectively. Quality of life was monitored through the use of the Functional Assessment of Cancer Therapy - Breast questionnaire.
Results
After chemotherapy (T1), the intake of macro and micronutrients did not change significantly, but the intake of fruits and juices increased (p=0.03). The opposite was observed regarding the preference for black coffee (p=0.01) and for the beverages group (p<0.001). Fat-rich foods (38%), dairy (23%), black coffee (15%), tea (15%), chocolate (7%) and red meats (7%) were the main foods associated with patient discomfort. Analyses of the quality of life showed that chemotherapy caused a significant reduction of physical well-being (p<0.01). After chemotherapy, some eating behavior variables were significantly correlated with quality of life parameters.
Conclusion
Chemotherapy caused the bilateral relationship between eating behavior and quality of life to change in a negative manner.
References
Shapiro SL, Lopez AM, Schwartz GE, Bootzin R, Figueredo AJ, Braden CJ, et al. Quality of life and breast cancer: relationship to psychosocial variables. J Clin Psychol. 2001; 57(4):501-19. doi:10.1002/jclp.1026.
Global Cancer Statistics [homepage na internet]. Paris: International Agency for Research on Cancer. [cited 2007 Jan 21]. Available from: <http://www.iarc.fr>.
Rock CL, Demark-Wahnefried W. Nutrition and survival after the diagnosis of breast cancer: a review of the evidence. J Clin Oncol. 2002; 20(15): 3302-16. doi:10.1200/JCO.2002.03.008.
Stull VB, Snyder DC, Demark-Wahnefried W. Lifestyle interventions in cancer survivors: designing programs that meet the needs of this vulnerable and growing population. J Nutr. 2007; 137(Suppl. 1): 243s-8s.
Instituto Nacional do Câncer. Estimativa 2008: incidência de câncer no Brasil. Rio de Janeiro: INCA; 2007.
Pinho VFS, Coutinho ESF. Risk factors for breast cancer: a systematic review of studies with female samples among the general population in Brazil. Cad Saúde Pública. 2005; 21(2):351-60. doi: 10.1590/S0102-311X2005000200002.
Williams SA, Schreier AM. The effect of education in managing side effects in women receiving chemotherapy for treatment of breast cancer. Oncol Nurs Forum. 2004; 31(1):16-23. doi: 10.1188/04.ONF.E16-E23.
Comeau TB, Epstein JB, Migas C. Taste and smell dysfunction in patients receiving chemotherapy: a review of current knowledge. Support Care Cancer. 2001; 9(8):575-80. doi:10.1188/04.ONF.E16-E23.
Epstein JB, Phillips N, Parry J, Epstein MS, Nevill T, Stevenson-Moore P. Quality of life, taste, olfactory and oral function following high-dose chemotherapy and allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 2002; 30(11):785-92. doi:10.1038/sj.bmt.1703716.
Berteretche MV, Dalix AM, d’Ornaro AM, Bellisle F, Khayat D, Faurion A. Decreased taste sensitivity in cancer patients under chemotherapy. Support Care Cancer. 2004; 12(8):571-6. doi:10.1007/s00520-004-0589-2.
Mattes RD, Arnold C, Boraas M. Learned food aversion among cancer chemotherapy patients: incidence, nature, and clinical implications. Cancer. 1987; 60(10):2576-80. doi:10.1002/1097-0142(19871115)60:10.
Ravasco P. Aspects of taste and compliance in patients with cancer. Eur J Oncol Nurs. 2005; 9(S2): 84-91. doi:10.1016/j.ejon.2005.09.003.
Mattes RD, Curran Jr WJ, Alavi J, Powlis W, Whittington R. Clinical implications of learned food aversions in patients with cancer treated with chemotherapy or radiation therapy. Cancer. 1992; 70(1):192-200. doi:10.1002/1097-0142(19920701) 70:1.
Arora NK, Gustafson DH, Hawkins RP, McTavish F, Cella DF, Pingree S, et al. Impact of surgery and chemotherapy on the quality of life of younger women with breast carcinoma: a prospective study. Cancer. 2001; 92(5):1288-98.
Kuroi K, Shimozuma K, Ohsumi S, Imai H, Ono M. Current status of health outcome assessment of medical treatment in breast cancer. Breast Cancer. 2007; 14(1):74-80. doi:10.2325/jbcs.14.74.
Fletcher RH, Fletcher SW, Wagner EH. Epidemiologia clínica: elementos essenciais. 3a. ed. Porto Alegre: Artes Médicas; 1996.
Harvie M, Howell A, Vierkant RA, Kumar N, Cerhan JR, Kelemen LE, et al. Association of gain and loss of weight before and after menopause with risk of postmenopausal breast cancer in the Iowa women’s health study. Cancer Epidemiol Biomarkers Prev. 2005. 14(3):656-61. doi: 10.1158/1055-9965.EPI-04-0001.
Duarte AC, Castellani FR. Semiologia nutricional. Rio de Janeiro: Axcel Books do Brasil; 2002.
World Health Organization. The problem of overweight and obesity. In: Obesity: preventing and managing the global epidemic. Geneva: World Health Organization; 2000. WHO Technical Report Series, 897.
Schutz HG. A food action rating scale for measuring food acceptance. J Food Sci. 1965; 30:365-74. doi: 10.1111/j.1365-2621.1965.tb00316.x.
NutWin: programa de apoio à nutrição [CD-Rom]. Versão 1.5. São Paulo: Unifesp; 2002.
Brady MJ, Cella DF, Mo F, Bonome AE, Tulsky DS, Lloyd SR, et al. Reliability and validity of the functional assessment of cancer therapy-breast quality-of-life instrument. J Clin Oncol. 1997; 15(3):974-86.
Epidata, version 3.1 [software internet]. Denmark: Epidata Association; 2005 [cited 2005 Sept]. Available from: <http://www.epidata.com.br>.
Statistical Package for the Social Science [CD-Rom]. Version 13.0. Chicago: Incorporation, 2000.
SAS for DOS [CD-Rom]. Version 9.1.3. Cary (NC): SAS Institute, 2006.
Minitab Statistical [CD-Rom]. Version 14. State College (PA): Minitab Inc; 2003.
Mols F, Vingerhoets AJ, Coebergh JW, van de PollFranse LV. Quality of life among long-term breast cancer survivors: a systematic review. Eur J Cancer. 2005; 41(17):2613-19. doi:10.1016/j.ejca.2005.05.017.
Simes RJ, Coates AS. Patient preferences for adjuvant chemotherapy of early breast cancer: how much benefit is needed? J Natl Cancer Inst Monogr. 2001; (30):146-52.
Knibb RC, Smith DM, Booth DA, Armstrong AM, Platts RG, MacDonald A, et al. No unique role for nausea attributed to eating a food in the recalled acquisition of sensory aversion for that food. Appetite. 2001; 36(3):225-34. doi: 10.1006/appe. 2001.0402.
Jacobsen PB, Bovbjerg DH, Schwartz MD, Andrykowski MA, Futterman D, Gilewski T, et al. Formation of food aversion in cancer patients receiving repeated infusions of chemotherapy. Behav Res Ther. 1993; 31(8):738-48. doi:10.1016/0005-7967(93)90004-E.
Holmes S. Food avoidance in patients undergoing cancer chemotherapy. Support Care Cancer. 1993; 1(6):326-30.
Garcia RWD. Práticas e comportamento alimentar no meio urbano: um estudo no centro da cidade de São Paulo. Cad Saúde Pública. 1997; 13(3): 455-467. doi:10.1590/S0102-311X1997000300021.
Viana V. Psicologia, saúde e nutrição: contributo para o estudo do comportamento alimentar. Anál Psicol. 2002; 20(4):611-24.
McEligot AJ, Rock CL, Sobo EJ, Flatt SW. Food avoidance by women at risk for recurrence of breast cancer. J Cancer Educ. 2000; 15(3):151-5.
Asbury N, Walshe A. Involving women with breast cancer in the development of a patient information leaflet for anticipatory nausea and vomiting. Eur J Oncol Nurs. 2005; 9(1):33-43. doi:10.1016/j.ejon.2004.07.003.
Wickham RS, Rehwaldt M, Kefer C, Shott S, Abbas K, Glynn-Tucker E, et al. Taste changes experienced by patients receiving chemotherapy. Oncol Nurs Forum. 1999; 26(4):697-706.
Albert US, Koller M, Wagner U, Schultz KD. Survival chances and psychological aspects of quality of life in patients with localized early stage breast cancer. Inflamm Res. 2004; 53(2S):136-41. doi:10.1007/s00011-004-0365-2.
Aslani A, Smith RC, Allen BJ, Pavlakis N, Levi JA. Change in body composition during breast cancer chemotherapy with the CMF-regimen. Breast Cancer Res Treat. 1999; 57(3):285-90.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Sara Maria Moreira Lima VERDE, Bruna Mara Okano SÃO PEDRO, Mário MOURÃO NETTO, Nágila Raquel Teixeira DAMASCENO
This work is licensed under a Creative Commons Attribution 4.0 International License.
